US Patent 10526326 Crystalline form and acetic acid adducts of palbociclib
Patent 10526326 was granted and assigned to Ratiopharm on January, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 11 Dec, 2023
Golden AI
Edits made to:
Article (+343 characters)
Article
Patent abstract
The present invention relates to an adduct of palbociclib, a method of preparing the preparing the same, and a pharmaceutical composition comprising the same. More particularly, the invention provides a crystalline form of palbociclib, a method of preparing the same, as well as a pharmaceutical composition comprising the same.
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Jens Geier0
Ludovic Coutable0
Manfred Erdmann0
Wolfgang Albrecht0
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
105263260
Date of Patent
January 7, 2020
0Patent Application Number
157491000
Date Filed
July 12, 2016
0Patent Primary Examiner
Edits on 31 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10526326 Crystalline form and acetic acid adducts of palbociclib
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10526326
Date of patent
January 7, 2020
Patent application number
15749100
Date Filed
July 12, 2016
Patent primary examiner
Find more entities like US Patent 10526326 Crystalline form and acetic acid adducts of palbociclib
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.